-1.330 (-1.68%)
Range 77.670 - 79.140   (1.89%)
Open 78.790
Previous Close 79.400
Buy Price 101.850
Buy Volume -
Sell Price 101.860
Sell Volume -
Volume 1,313,932
Value -
Measurement Type Value
EPS (USD) 1.684
Trailing EPS (USD) 1.196
NAV (USD) 6.175
Cash In Hand (USD) 1.453
Dividend -
Dividend Yield (%) -
PE 45.527
Trailing PE 64.097
Price / NAV 12.415
Price / Cash In Hand 52.753
Issued & Paid-up Shares 621,741,000
Treasury Shares 12,100,000
Market Cap (M) 47,662.665
Par Value (USD) n.a.
Beta - 75 Days -
R-Squared - 75 Days(%) -
Beta - 500 Days -
R-Squared - 500 Days(%) -
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 15 Aug 2020 04:00.
Data powered by

Upcoming Events

* Stock event date based on US timezone.


Release Date 27 Oct 2020
View All Events


Edwards Lifesciences Corporation (Edwards Lifesciences) is focused on technologies that treat structural heart disease and critically ill patients. A pioneer in the development and commercialization of heart valve products, Edwards Lifesciences is the manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. The Company also provides hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The products and technologies provided by Edwards Lifesciences to treat advanced cardiovascular disease or critically ill patients are categorized into three main areas: Surgical Heart Valve Therapy, which combines surgical heart valves and Cardiac Surgery Systems; Transcatheter Heart Valves; and Critical Care, which includes Vascular. In October 2012, it acquired BMEYE B.V.

Loading Chart...